Regulation & policy

Credit where credit is due: FDA activity is a good thing

FDA's enforcement deserves loud applause

By Stephen Daniells

A flurry of seizures, criminal charges, and warning letters shows that FDA is increasing it enforcement of dietary supplement regulations. Good for FDA and good for industry!

EPA/DHA: How much is enough?

GOED: US food manufacturers want clarity on omega-3 DRIs

By Elaine Watson

Global omega-3 EPA and DHA organization GOED has heard positive signs that if and when a new Institute of Medicine (IOM) dietary reference intake (DRI) project is commissioned in the US, omega-3s will be “near the top of the list”.

Mister: Daily values rule change is bad news for consumers (and for us)

Dispatches from SupplySide East

Mister: Daily values rule change is bad news for consumers (and for us)

By Elaine Watson, New Jersey

Proposals by the FDA (Food and Drug Administration) to change how daily values on food labels are calculated are not in the interests of the dietary supplements industry or consumers, the Council for Responsible Nutrition (CRN) has warned.

Ullman & Mackay: Not happy

Dispatches from SupplySide East

NDI guidance could be 'gamechanger' for supplements trade

By Elaine Watson, Secaucus, New Jersey

Fears are mounting that the Food and Drug Administration’s (FDA’s) long-awaited guidance on new dietary ingredients (NDIs) could prove a “game changer” for the industry, and not in a good way.

Sodium vs. salt: Let’s agree to disagree

Sodium vs. salt: Let’s agree to disagree

By Caroline Scott-Thomas

The United States lists sodium on nutrition labels while salt is more common in the European Union. Salt and sodium are not the same, and a standardized term would only cause confusion.

‘Really outrageous’ claims on the wane in print/TV, says CRN

‘Really outrageous’ claims on the wane in print/TV, says CRN

By Elaine Watson

False and misleading claims – particularly on the web – continue to dent consumer confidence in supplements, but there are “fewer really outrageous claims on print and on TV today than there were five years ago”, according to the Council for Responsible...

FDA should allow for dietary supplements, says CRN

CRN: Phytosterol health claim should allow dietary supplements

By Stephen Daniells

The FDA’s proposed changes for a phytosterol-based coronary heart disease (CHD)-lowering health claim should allow for powdered dietary supplements containing free phytosterols, says the Council for Responsible Nutrition (CRN).

NPA: If drugs get tax breaks, why not supplements with FDA-approved claims?

NPA: Supplements backed by official health claims deserve tax breaks

By Elaine Watson

A Bill set to be introduced to Congress for the fourth time calling for tax breaks for dietary supplements backed by official health claims has a much better chance of success this time around, the Natural Products Association (NPA) has predicted.

The Yo-Plus case was not prompted by FDA or FTC

Class action lawsuits set to ‘explode’ in health claims arena

By Elaine Watson

A potent combination of lawyers on the make, a rise in activism from consumer lobby groups and food manufacturers pushing the envelope with more aggressive health claims is set to prompt an “explosion” in class action lawsuits in the coming years, according...

Purveyors of substandard raw materials will be

China tightens raw materials laws for supplements makers

By Shane Starling

Dietary supplement manufacturers operating in China will have to do more to guarantee the quality of their supply chains, after Chinese authorities imposed new quality control regulations last week.

Will Australia and New Zealand join Europe, Canada and the US by authorising hemp foods?

Australia ponders legalising hemp foods

By Shane Starling

Australian regulators are considering allowing non-psychoactive versions of fatty acid and nutrient-rich hemp into the food supply and have opened a public consultation on the matter.

Not an amino acid finds FDA in rejecting homotaurine as an NDI

FDA rejects homotaurine NDI bid; finds it is not an amino acid

By Shane Starling

The Food and Drug Administration has rejected Canadian biotech firm Ovos’s bid to win NDI status for its homotaurine brain health ingredient because the agency says the nutrient found in certain seaweeds is not an amino acid.

Welch's resolves to pay $30m to settle class actions, but its battle with POM Wonderful over labelling is not over

Welch’s to pay $30m over misleading juice claims

By Shane Starling

Welch’s will pay $30m to consumers misled by labeling for its ‘100% Juice White Grape Pomegranate’ after settling class actions in a California court this month. Welch’s has responded to another class action in a Florida court that is yet to be resolved.

FDA is working with Customs officials to stop the flow of unauthorized herbals into the country

FDA and Customs cracking down on fake herbal Viagra

By Shane Starling

US Customs and Border Protection (CBP) and the Food and Drug Administration (FDA) are employing “Predictive Risk-based Evaluation” to target economically motivated adulteration of erectile dysfunction and other unauthorized supplements at US borders.

Follow us

Products

View more

Webinars